Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Depressive Disorder, Major × Infliximab × Clear all

Phase

Phase 4 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Arthritis, Rheumatoid 2 Lymphoma 1 Inflammatory Bowel Diseases 1 Depressive Disorder, Treatment-Resistant 1 Depressive Disorder, Major 1 Depression 1 Crohn Disease 1 Colitis, Ulcerative 1 Bipolar Disorder 1 Autoimmune Diseases 1 Arthritis, Psoriatic 1

Interventions

Venlafaxine Hydrochloride 1 Saline Solution 1 Interpersonal Psychotherapy 1 Infliximab 1 Escitalopram 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00463580 2025-07-08

Infliximab

Emory University

Phase 4 Completed

60 enrolled 15 charts

Bipolar Disorder, Depression, Depressive Disorder, Major, Depressive Disorder, Treatment-Resistant

Data powered by HemOnc (CC BY 4.0) Colophon ⚡